Skip to search formSkip to main contentSkip to account menu

Bromocriptine 2.5 MG Oral Tablet [Parlodel]

Known as: BROMOCRIPTINE MESYLATE 2.5 mg ORAL TABLET [Parlodel], Parlodel 2.5 MG Oral Tablet, Parlodel SnapTabs 2.5 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

11 relations
2-Bromoergocryptine MesylateBromocriptineIsopropyl AlcoholLactose

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Parlodel SRO in Parkinson's disease: a double-blind randomized comparison of Parlodel standard and Parlodel SRO.
In this study, we compared in an intent-to-treat analysis the tolerance and efficacy of Parlodel SRO with its standard galenic… 
1992
1992
Long-acting oral bromocriptine (Parlodel SRO)**Parlodel SRO, Sandoz, Basel, Switzerland. in the treatment of hyperprolactinemia††Supported in part by Sandoz, Basel, Switzerland.
1991
1991
Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
The efficacy and tolerability of a slow-release preparation of bromocriptine (Parlodel SRO) were compared to those of… 
1991
1991
A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
Parlodel SRO, a new slow release form of bromocriptine, was studied in 26 patients with tumoral and non-tumoral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)